"CD47 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A ubiquitously expressed membrane glycoprotein. It interacts with a variety of INTEGRINS and mediates responses to EXTRACELLULAR MATRIX PROTEINS.
Descriptor ID |
D051928
|
MeSH Number(s) |
D12.776.395.550.014 D12.776.543.550.147
|
Concept/Terms |
CD47 Antigen- CD47 Antigen
- Antigen, CD47
- CD47 Antigens
- IAP-50 Antigen
- Antigen, IAP-50
- IAP 50 Antigen
- Antigens, CD47
- Thrombospondin-1 Receptor CD47
- CD47, Thrombospondin-1 Receptor
- Integrin-Associated Protein p50
- Integrin Associated Protein p50
|
Below are MeSH descriptors whose meaning is more general than "CD47 Antigen".
Below are MeSH descriptors whose meaning is more specific than "CD47 Antigen".
This graph shows the total number of publications written about "CD47 Antigen" by people in this website by year, and whether "CD47 Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2017 | 1 | 1 | 2 |
2018 | 2 | 0 | 2 |
2022 | 2 | 1 | 3 |
2023 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD47 Antigen" by people in Profiles.
-
Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T-cell Immunity in Gastric Cancer Peritoneal Metastases. Cancer Res. 2023 11 15; 83(22):3726-3738.
-
CD47 expression is critical for CAR T-cell survival in vivo. J Immunother Cancer. 2023 03; 11(3).
-
Neuronal signal-regulatory protein alpha drives microglial phagocytosis by limiting microglial interaction with CD47 in the retina. Immunity. 2022 12 13; 55(12):2318-2335.e7.
-
Inhibition of the CD47-SIRPa axis for cancer therapy: A systematic review and meta-analysis of emerging clinical data. Front Immunol. 2022; 13:1027235.
-
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer. Sci Immunol. 2022 06 10; 7(72):eabl9330.
-
Display of Self-Peptide on Adeno-Associated Virus Capsid Decreases Phagocytic Uptake in Vitro. ACS Synth Biol. 2020 09 18; 9(9):2246-2251.
-
Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma. Innate Immun. 2020 02; 26(2):130-137.
-
Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia. Leukemia. 2019 04; 33(4):931-944.
-
Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity. Proc Natl Acad Sci U S A. 2018 06 26; 115(26):6786-6791.
-
Anti-CD47 monoclonal antibody therapy reduces ischemia-reperfusion injury of renal allografts in a porcine model of donation after cardiac death. Am J Transplant. 2018 04; 18(4):855-867.